Volume 17, Number 12—December 2011
Letter
Rift Valley and West Nile Virus Antibodies in Camels, North Africa
Mehdi El-Harrak, Raquel Martín-Folgar, Francisco Llorente, Paloma Fernández-Pacheco, Alejandro Brun, Jordi Figuerola, and Miguel Ángel Jiménez-Clavero
Table
Results of testing of camels for virus antibodies, by location, age group, and sex of camels examined, North Africa, 2009*
| Camel characteristic | No. samples | No. positive for antibody |
|||
|---|---|---|---|---|---|
| RVFV | WNV | AHSV | RVFV and WNV | ||
| Origin | |||||
| Tata | 2 | 0 | 0 | 0 | 0 |
| Smara-Laayoune | 58 | 13 | 20 | 0 | 11 |
| Dakhla | 40 | 2 | 9 | 0 | 1 |
| Age group, y | |||||
| <1 | 18 | 1 | 1 | 0 | 1 |
| 1–2 | 25 | 0 | 1 | 0 | 0 |
| 3–5 | 7 | 1 | 3 | 0 | 1 |
| 6–10 | 27 | 6 | 12 | 0 | 10 |
| >10 | 23 | 7 | 12 | 0 | 0 |
| Sex | |||||
| M | 71 | 10 | 15 | 0 | 7 |
| F | 29 | 5 | 14 | 0 | 5 |
| Total | 100 | 15 | 29 | 0 | 12 |
*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus.
Page created: November 18, 2011
Page updated: November 18, 2011
Page reviewed: November 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.